| 1 |
34481952 | A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States. | 2022 Jan |
1 |
| 2 |
33040554 | Rectal diclofenac for prevention of post-endoscopic retrograde cholangiography pancreatitis. | 2021 Feb |
1 |
| 3 |
33444486 | Combination prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in patients undergoing double-guidewire assisted biliary cannulation: A case-control study with propensity score matching. | 2021 Jul |
2 |
| 4 |
34222616 | Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis. | 2021 Jul |
1 |
| 5 |
34353727 | Combined use of indomethacin and hydration is the best conservative approach for post-ERCP pancreatitis prevention: A network meta-analysis. | 2021 Oct |
1 |
| 6 |
34487093 | Comparison of stent and indomethacin suppository efficacy in the prevention of acute pancreatitis after ERCP. | 2021 Sep 2 |
3 |
| 7 |
32496740 | Real-World Practice Patterns in the Era of Rectal Indomethacin for Prophylaxis Against Post-ERCP Pancreatitis in a High-Risk Cohort. | 2020 Jun |
1 |
| 8 |
32624662 | Rectal indomethacin reduces the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis in low-risk patients. | 2020 Jul-Aug |
1 |
| 9 |
33188441 | Emerging Therapies to Prevent Post-ERCP Pancreatitis. | 2020 Nov 13 |
1 |
| 10 |
31192286 | Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in the Indomethacin Era - A Prospective Study. | 2019 May |
2 |
| 11 |
29980976 | Risk Factors for Post-ERCP Pancreatitis in High-Risk Patients Receiving Post-procedure Rectal Indomethacin. | 2018 Nov |
3 |
| 12 |
27849643 | Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. | 2017 Mar |
2 |